Quick Answer
QIAGEN N.V. reported Long Term Debt of $1.65 billion for the year ending 2025.
- QIAGEN N.V. showed an increase of +97.0% in Long Term Debt from 2024 to 2025.
- This data is from QIAGEN N.V.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), QIAGEN N.V.'s Long Term Debt has grown by 90.2%.
- Historical annual values: Fiscal year 2025: $1.65 billion | Fiscal year 2024: $839.67 million | Fiscal year 2023: $921.82 million | Fiscal year 2022: $1.47 billion | Fiscal year 2021: $1.09 billion | Fiscal year 2020: $1.88 billion | Fiscal year 2019: $1.42 billion | Fiscal year 2018: $1.67 billion | Fiscal year 2017: $1.76 billion | Fiscal year 2016: $1.07 billion | Fiscal year 2015: $1.05 billion | Fiscal year 2014: $1.04 billion | Fiscal year 2013: $845.28 million | Fiscal year 2012: $846.04 million | Fiscal year 2011: $446.01 million | Fiscal year 2010: $797.17 million | Fiscal year 2009: $870.00 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: